PL8177 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎1

97. 潰瘍性大腸炎


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05466890
(ClinicalTrials.gov)
September 15, 202225/5/2022Phase 2a To Evaluate PL-8177 in Subjects With Active Ulcerative Colitis (UC)Phase 2a, Double-Blind, Randomized Adaptive Design, Placebo-Controlled, Parallel Group Study to Evaluate the Safety, Tolerability, Efficacy, PK and Biomarkers With Oral Colon Delivery PL8177 in Adult Subjects With Active Ulcerative ColitisUlcerative Colitis;Ulcerative Colitis Acute;Ulcerative;Ulcerative Colitis FlareDrug: PL8177 Placebo;Drug: PL8177Palatin Technologies, IncNULLRecruiting18 Years75 YearsAll28Phase 2United States